ZYDUS LIFESCIENCES LTD.

NSE : ZYDUSLIFEBSE : 532321ISIN CODE : INE010B01027Industry : Pharmaceuticals & DrugsHouse : Cadila
BSE933.40-26.15 (-2.73 %)
PREV CLOSE ( ) 959.55
OPEN PRICE ( ) 958.55
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 106129
TODAY'S LOW / HIGH ( )914.05 958.55
52 WK LOW / HIGH ( )482.55 1031.3
NSE933.50-25.95 (-2.7 %)
PREV CLOSE( ) 959.45
OPEN PRICE ( ) 958.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 933.50 (245)
VOLUME 3433345
TODAY'S LOW / HIGH( ) 914.50 958.95
52 WK LOW / HIGH ( )484.95 1031.7
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax25827.0052323.0022848.0014954.0023821.00
Adjustment9339.00-21172.0011630.0014744.005391.00
Changes In working Capital-2358.00-3360.001911.002638.00-9717.00
Cash Flow after changes in Working Capital32808.0027791.0036389.0032336.0019495.00
Cash Flow from Operating Activities26888.0021045.0032939.0029315.0012819.00
Cash Flow from Investing Activities11712.00-10003.00-7246.00-10123.00-42387.00
Cash Flow from Financing Activities-44004.00-8683.00-25477.00-15282.0018846.00
Net Cash Inflow / Outflow-5404.002359.00216.003910.00-10722.00
Opening Cash & Cash Equivalents11069.008883.0011777.007788.0015897.00
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNA-259.00-1079.00NA2613.00
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange Fluctuations66.0086.00-42.0079.00NA
Closing Cash & Cash Equivalent5731.0011069.0010872.0011777.007788.00

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.